I agree that this site is using cookies. You can find further informations here.
X
Pathak, Sanjeev
260  results:
Search for persons X
?
1

Challenges and proposed solutions to conducting Alzheimer's..:

Ballard, Clive ; Tariot, Pierre ; Soto-Martin, Maria..
Frontiers in Psychiatry.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Does Ownership Influence Corporate Social Responsibility (C..:

Pathak, Sanjeev ; Tripathy, Arun Kumar ; Panda, Abinash
Journal of Law and Sustainable Development.  12 (2024)  1 - p. e2417 , 2024
Link: https://doi.org/10.55908..
 
?
3

Safety Profile of Pimavanserin Therapy in Elderly Patients ..:

Alva, Gus ; Cubała, Wiesław J. ; Berrio, Ana...
Journal of Alzheimer's Disease.  98 (2024)  1 - p. 265-274 , 2024
Link: https://doi.org/10.3233/..
 
?
4

Pimavanserin for psychosis in Parkinson's disease dementia:..:

Weintraub, Daniel ; Espay, Alberto J. ; Sharma, Vibhash D....
Parkinsonism & Related Disorders.  119 (2024)  - p. 105951 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Focus on Social and Sustainability Goals: The Blurring Line..:

, In: Digital Economy Post COVID-19 Era; Springer Proceedings in Business and Economics,
Pathak, Sanjeev ; Tripathy, Arun Kumar ; Panda, Abinash - p. 457-465 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Safety profile of pimavanserin therapy in elderly patients ..:

Alva, Gustavo ; Cubała, Wiesław J. ; Berrio, Ana...
Alzheimer's & Dementia.  19 (2023)  S21 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
7

Efficacy and safety of pimavanserin in patients with Alzhei..:

Cummings, Jeffrey ; Devanand, Davangere P ; Ballard, Clive G...
Alzheimer's & Dementia.  18 (2022)  S10 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
8

Pimavanserin treatment of hallucinations and delusions in p..:

Weintraub, Daniel ; Espay, Alberto ; Sharma, Vibhash...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
9

Renewable Energy Transition for the Himalayan Countries Nep..:

Gulagi, Ashish ; Pathak, Sanjeev ; Bogdanov, Dmitrii.
IEEE Access.  9 (2021)  - p. 84520-84544 , 2021
Link: https://doi.org/10.1109/..
 
?
10

Results from a long-term open-label extension study of adju..:

Thase, Michael E. ; Stanford, Arielle D. ; Memisoglu, Asli...
Neuropsychopharmacology.  44 (2019)  13 - p. 2268-2276 , 2019
Link: https://doi.org/10.1038/..
 
?
11

Buprenorphine/samidorphan combination for the adjunctive tr..:

Zajecka, John M ; Stanford, Arielle D ; Memisoglu, Asli..
Neuropsychiatric Disease and Treatment.  15 (2019)  - p. 795-808 , 2019
Link: https://doi.org/10.2147/..
 
?
12

50 Adjunctive Buprenorphine/Samidorphan Combination in Pati..:

Thase, Michael ; Stanford, Arielle D. ; Memisoglu, Asli...
CNS Spectrums.  24 (2019)  1 - p. 203-204 , 2019
Link: https://doi.org/10.1017/..
 
?
13

5 Clinical Evaluation of the Abuse Potential of Buprenorphi..:

Cutler, Andrew J. ; Mathew, Sanjay J. ; DeBakey, Michael E....
CNS Spectrums.  24 (2019)  1 - p. 176-176 , 2019
Link: https://doi.org/10.1017/..
 
?
14

S99. Evaluation of Abuse Potential of Samidorphan in Health..:

Setnik, Beatrice ; Nangia, Narinder ; Puhl, Matthew D....
Biological Psychiatry.  83 (2018)  9 - p. S385 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Abuse Potential of Buprenorphine/Samidorphan Combination Co..:

Pathak, Sanjeev ; Vince, Bradley ; Kelsh, Debra...
The Journal of Clinical Pharmacology.  59 (2018)  2 - p. 206-217 , 2018
Link: https://doi.org/10.1002/..
 
1-15